Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

M. Santoni, U. De Giorgi, R. Iacovelli, A. Conti, L. Burattini, L. Rossi, S. Luca Burgio, R. Berardi, G. Muzzonigro, E. Cortesi, D. Amadori, S. Cascinu

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences